Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Immunohistochemistry Single Marker Without Interpretation Test

A diagnostic test using immunohistochemistry to identify specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning. Results are provided without interpretation.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Tumor tissue in 10% Formal-saline or Formalin fixed paraffin embedded block. A copy of the Histopathology report, Site of biopsy, and Clinical history must be provided.
Results
Report available in 5 days for Block and Tissue Biopsy samples, and 7 days for Tissue Large Complex samples. Sample must be submitted daily by 6 PM.
Preparation
No specific patient preparation is required. Ensure the tissue sample is correctly collected and preserved.
Test priceKSh 2,340

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunohistochemistry Single Marker Without Interpretation Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Cancer diagnosis confirmation
  • ✓Tumor subtyping
  • ✓Guiding treatment decisions
  • ✓Monitoring treatment response
  • ✓Research purposes
  • ✓Identifying specific protein expression in tissue
02

In plain language

What this test helps you understand

This test aids in the identification of specific proteins within tumor tissues, providing essential information for cancer diagnosis, treatment planning, and monitoring.
The Immunohistochemistry Single Marker Without Interpretation Test is a diagnostic tool used primarily in oncology. It helps identify specific proteins within tumor tissues, providing essential information for cancer diagnosis and treatment planning. By analyzing these markers, healthcare professionals can better understand the nature of the cancer and tailor treatment strategies. This test measures the presence of specific tumor markers in tissue samples using immunohistochemistry techniques to detect proteins associated with certain cancers. The results help oncologists and pathologists make informed decisions regarding patient management and therapy options.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Ensure the tissue sample is correctly collected and preserved.
SampleTumor tissue in 10% Formal-saline or Formalin fixed paraffin embedded block. A copy of the Histopathology report, Site of biopsy, and Clinical history must be provided.
MethodologyImmunohistochemistry (IHC) is used to detect specific proteins (antigens) in tissue sections using antibodies.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies the presence or absence of a specific marker but does not provide interpretation of the findings. Results must be interpreted in the context of the patient's clinical history and other diagnostic tests. The accuracy depends on the quality of the tissue sample provided.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Immunohistochemistry (IHC) is a laboratory technique that uses antibodies to detect specific proteins (antigens) in tissue samples.
This means the laboratory will provide the results of the marker detection, but a pathologist or oncologist will need to interpret these results in the context of your overall medical situation.
A tissue sample, typically a biopsy or surgical resection, preserved in formalin or embedded in paraffin wax, is required.
Results are typically available within 5 to 7 days, depending on the type of tissue sample submitted. Confirm with the laboratory before booking.
No specific patient preparation is required for this test, as it uses a tissue sample.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp